Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Stockwatch: Mistaken Acquisitions Dim Earnings Season

Jan 30 2017

• By Andy Smith

Stockwatch

Related Content

Fresh From The White House, J&J's Gorsky Talks Policy, Drug Pricing

Jan 25 2017

J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value

Jan 26 2017

Can Slow Selling Heart Drug Entresto Perk Up In 2017? Novartis Hopes So

Jan 25 2017

Biogen Hemophilia Spin Out Bioverativ On Track For Early 2017

Aug 09 2016

Emicizumab Data Has Shire And Novo Looking Over Their Shoulders

Dec 22 2016

Shire & Baxalta Seal The Deal

May 27 2016

Related Companies

Viatris Inc.

Lannett Company, Inc.

Teva Pharmaceutical Industries Ltd.

Meda AB

Lannett Company, Inc.

Allergan plc

Takeda Pharmaceutical Co. Ltd.

Baxalta Incorporated

Johnson & Johnson

Inverness Medical Technology Inc.

Novartis AG

Actelion Pharmaceuticals Ltd.

Pharmacyclics, Inc.

AbbVie Inc.

Biogen, Inc.

Sanofi

Roche Holding AG

Additional Topics

Sales & Earnings M & A Commercial Companies BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window